Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Successful Long-Term Enzyme Replacement Therapy in a Patient with Delayed-Onset ADA Deficiency.

Journal of clinical immunology - 12 Sept 2024

Toskov Vasil, Bali Pawan, Hershfield Michael S, Ehl Stephan, Speckmann Carsten

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine Deaminase
Share to Agammaglobulinemia
Share to Enzyme Replacement Therapy
Share to ADA gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Severe Combined Immunodeficiency

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 39264481
DOI: 10.1007/s10875-024-01794-7
PMCID: PMC11393103

Genes

ADA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Successful Long-Term Enzyme Replacement Therapy in a Patient with Delayed-Onset ADA Deficiency.PMID 39264481Read ↗

Diagnosis, Treatment and Long-Term Follow Up of Patients with ADA Deficiency: a Single-Center Experience.Semantic proximity Read ↗

Long Term Treatment with Enzyme Replacement Therapy in Patients with Fabry DiseaseSemantic proximity Read ↗

In Vivo Transduction by Intravenous Injection of a Lentiviral Vector Expressing Human ADA into Neonatal ADA Gene Knockout Mice: A Novel Form of Enzyme Replacement Therapy for ADA DeficiencySemantic proximity Read ↗

Successful management of delayed-onset adenosine deaminase deficiency with novel mutation.Semantic proximity Read ↗

Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10year combined experience of 2 centresSemantic proximity Read ↗

Cessation of enzyme replacement therapy in Gaucher disease.Semantic proximity Read ↗

Replacement therapy for hereditary alpha1-antitrypsin deficiency. A program for long-term administration.Semantic proximity Read ↗

Successful Peripheral T-Lymphocyte–Directed Gene Transfer for a Patient With Severe Combined Immune Deficiency Caused by Adenosine Deaminase DeficiencySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.